Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy

BACKGROUND AND AIMS: Clinical trials of therapy against chronic hepatitis C virus (HCV) infection including boceprevir (BOC) or telaprevir (TVR) plus pegylated interferon and ribavirin (PR) have reported considerably higher response rates than those achieved with PR alone. This study sought to evalu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Neukam, Karin, Munteanu, Daniela I., Rivero-Juárez, Antonio, Lutz, Thomas, Fehr, Jan, Mandorfer, Mattias, Bhagani, Sanjay, López-Cortés, Luis F., Haberl, Annette, Stoeckle, Marcel, Márquez, Manuel, Scholten, Stefan, de los Santos-Gil, Ignacio, Mauss, Stefan, Rivero, Antonio, Collado, Antonio, Delgado, Marcial, Rockstroh, Juergen K., Pineda, Juan A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4414348/
https://ncbi.nlm.nih.gov/pubmed/25923540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0125080
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller